30 filings
8-K
MLTX
MoonLake Immunotherapeutics - Ordinary Shares
7 May 24
MoonLake Immunotherapeutics Reports First Quarter 2024 Financial Results and Provides a Business Update
8:01am
8-K
MLTX
MoonLake Immunotherapeutics - Ordinary Shares
11 Mar 24
Regulation FD Disclosure
8:01am
8-K
MLTX
MoonLake Immunotherapeutics - Ordinary Shares
29 Feb 24
MoonLake Immunotherapeutics Reports Full Year 2023 Financial Results, Recent Business Highlights and Announces an R&D Day on March 10
8:03am
8-K
MLTX
MoonLake Immunotherapeutics - Ordinary Shares
26 Feb 24
Regulation FD Disclosure
9:00am
8-K
MLTX
MoonLake Immunotherapeutics - Ordinary Shares
14 Nov 23
MoonLake Immunotherapeutics Reports Third Quarter 2023 Financial Results and Provides a Business Update
12:00am
8-K
4mx6o55b
6 Nov 23
MoonLake Immunotherapeutics announces landmark Phase 2 results for Nanobody® sonelokimab in active psoriatic arthritis
7:55am
8-K
d5qcnqy
16 Oct 23
Regulation FD Disclosure
6:16am
8-K
g3efvo0f
11 Sep 23
Regulation FD Disclosure
11:59am
8-K
1lb9lq der62op
1 Sep 23
Departure of Directors or Certain Officers
5:00pm
8-K
wtck85u103wgs3jpxe
10 Aug 23
MoonLake Immunotherapeutics Reports Second Quarter 2023 Financial Results and Provides a Business Update
8:15am
8-K
sp11d1 8sv898ngw8
29 Jun 23
Entry into a Material Definitive Agreement
4:13pm
8-K
k6u7g9mtljax 5910x
26 Jun 23
MoonLake Immunotherapeutics achieves landmark milestone with positive Phase 2 results for Nanobody® sonelokimab in hidradenitis suppurativa
8:45am
8-K
17dc 8c42jxxkvnc
7 Jun 23
Submission of Matters to a Vote of Security Holders
4:31pm
8-K
ggwetsq4v554rb
19 May 23
Departure of Directors or Certain Officers
4:30pm
8-K
hdggi20mil
19 Apr 23
Regulation FD Disclosure
9:15am
8-K
vdrrrwmdua2tp93
20 Mar 23
MoonLake Immunotherapeutics Reports Fourth Quarter and Year-End 2022 Financial Results and Provides a Business Update
7:44am
8-K
rjaxbjm92x06h59fyhf
10 Mar 23
Regulation FD Disclosure
5:07pm
8-K
eweimu50ugzys9q7o
17 Jun 22
Changes in Registrant's Certifying Accountant
4:05pm
8-K
obn06 g3hrtw
7 Jun 22
Regulation FD Disclosure
8:31am
8-K/A
q6zoftbu6
16 May 22
Completion of Acquisition or Disposition of Assets
4:10pm